HNB
VIR icon

Huntington National Bank’s Vir Biotechnology VIR Stock Holding History

Huntington National Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-33
Closed -$214 – 4237
2025
Q1 		$214 Hold
33
– – ﹤0.01% 2620
2024
Q4 		$242 Sell
33
-7
-18% -$55 ﹤0.01% 2636
2024
Q3 		$300 Buy
40
+19
+90% +$165 ﹤0.01% 2577
2024
Q2 		$187 Buy
+21
New +$201 ﹤0.01% 2622

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Huntington National Bank's VIR Position: Q2 2025 in Review

Huntington National Bank sold out of Vir Biotechnology (VIR) in Q2 2025, closing a stake of 33 shares — an estimated $214 sold.

Huntington National Bank first reported a position in VIR in Q2 2024 and held it in 4 quarters. The position peaked at $300 in Q3 2024. 213 funds tracked by Wall St. Rank hold VIR as of Q2 2025.

  • Huntington National Bank reported no remaining Vir Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Huntington National Bank sold 33 Vir Biotechnology shares in Q2 2025, an estimated $214.
  • Huntington National Bank first reported a position in Vir Biotechnology in Q2 2024 and held it in 4 quarters.
  • Huntington National Bank's Vir Biotechnology position peaked at $300 in Q3 2024.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.